Itron (NASDAQ:ITRI) Rating Lowered to “Hold” at Wall Street Zen

Itron (NASDAQ:ITRI) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday.

Several other research firms also recently weighed in on ITRI. Baird R W downgraded shares of Itron from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 31st. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Itron in a research report on Monday, December 8th. Oppenheimer set a $145.00 price target on Itron and gave the company an “outperform” rating in a research note on Friday, October 31st. Zacks Research downgraded Itron from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 12th. Finally, Argus reiterated a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Nine research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, Itron presently has a consensus rating of “Moderate Buy” and an average price target of $139.00.

Itron Price Performance

ITRI stock opened at $96.18 on Friday. The stock has a market cap of $4.41 billion, a PE ratio of 17.30, a P/E/G ratio of 0.47 and a beta of 1.52. Itron has a 12 month low of $90.11 and a 12 month high of $142.00. The company has a 50-day moving average price of $111.14 and a 200 day moving average price of $121.00. The company has a current ratio of 2.17, a quick ratio of 1.91 and a debt-to-equity ratio of 0.46.

Itron (NASDAQ:ITRI) last announced its quarterly earnings data on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.06. The business had revenue of $581.63 million during the quarter, compared to the consensus estimate of $578.49 million. Itron had a net margin of 10.69% and a return on equity of 17.82%. The firm’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.84 earnings per share. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. Equities research analysts anticipate that Itron will post 5.33 earnings per share for the current year.

Insider Activity

In other news, SVP Justin K. Patrick sold 379 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $36,577.29. Following the completion of the transaction, the senior vice president directly owned 20,382 shares of the company’s stock, valued at $1,967,066.82. This represents a 1.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP John F. Marcolini sold 553 shares of the business’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $96.51, for a total transaction of $53,370.03. Following the completion of the sale, the senior vice president directly owned 13,843 shares of the company’s stock, valued at approximately $1,335,987.93. The trade was a 3.84% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 2,971 shares of company stock worth $286,731. 1.51% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Itron

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Tudor Investment Corp ET AL lifted its stake in Itron by 47.2% in the 3rd quarter. Tudor Investment Corp ET AL now owns 274,644 shares of the scientific and technical instruments company’s stock valued at $34,210,000 after buying an additional 88,029 shares in the last quarter. Swiss Life Asset Management Ltd boosted its stake in shares of Itron by 0.8% in the third quarter. Swiss Life Asset Management Ltd now owns 111,772 shares of the scientific and technical instruments company’s stock worth $13,922,000 after acquiring an additional 874 shares during the last quarter. CIBC Private Wealth Group LLC increased its position in shares of Itron by 7.2% during the third quarter. CIBC Private Wealth Group LLC now owns 4,251 shares of the scientific and technical instruments company’s stock worth $530,000 after purchasing an additional 287 shares in the last quarter. CIBC Bancorp USA Inc. acquired a new stake in shares of Itron in the third quarter valued at about $604,000. Finally, Advisory Services Network LLC acquired a new position in Itron during the 3rd quarter worth about $49,000. 96.19% of the stock is owned by hedge funds and other institutional investors.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.